Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Hepatology International|April 6, 2023
Endoscopic band ligation is safe despite low platelet count and high INRNikolaus Pfisterer, Michael Schwarz, Mathias Jachs, et al.
Journal of Personalized Medicine|February 25, 2022
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral SuppressionMathias Jachs, Lukas Hartl, David Bauer, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|December 16, 2025
[Diagnostic challenges of Wernicke-Korsakoff syndrome: A case report]Paula Hoppstock, Lea Sommer, Mathias Jachs, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Scientific Reports|October 30, 2024
Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care centerJohannes Bernhard, Michael Schwarz, Lorenz Balcar, et al.
Journal of Clinical Medicine|June 11, 2020
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer PatientsMatthias Unseld, Sebastian Fischöder, Mathias Jachs, et al.
Plos One|June 13, 2024
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosisNikolaus Pfisterer, Michael Schwarz, Caroline Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Hepatology International|April 6, 2023
Endoscopic band ligation is safe despite low platelet count and high INRNikolaus Pfisterer, Michael Schwarz, Mathias Jachs, et al.
Journal of Personalized Medicine|February 25, 2022
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral SuppressionMathias Jachs, Lukas Hartl, David Bauer, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|December 16, 2025
[Diagnostic challenges of Wernicke-Korsakoff syndrome: A case report]Paula Hoppstock, Lea Sommer, Mathias Jachs, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2023
Diabetes impairs the haemodynamic response to non-selective betablockers in compensated cirrhosis and predisposes to hepatic decompensationRafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Scientific Reports|October 30, 2024
Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care centerJohannes Bernhard, Michael Schwarz, Lorenz Balcar, et al.
Journal of Clinical Medicine|June 11, 2020
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer PatientsMatthias Unseld, Sebastian Fischöder, Mathias Jachs, et al.
Plos One|June 13, 2024
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosisNikolaus Pfisterer, Michael Schwarz, Caroline Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2023
Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosisBenedikt Simbrunner, Lukas Hartl, Mathias Jachs, et al.
Pageof 12